These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 1976282)
1. Induction of donor-specific unresponsiveness to cardiac allografts in rats by pretransplant anti-CD4 monoclonal antibody therapy. Shizuru JA; Seydel KB; Flavin TF; Wu AP; Kong CC; Hoyt EG; Fujimoto N; Billingham ME; Starnes VA; Fathman CG Transplantation; 1990 Sep; 50(3):366-73. PubMed ID: 1976282 [TBL] [Abstract][Full Text] [Related]
2. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen. Arima T; Lehmann M; Flye MW Transplantation; 1997 Jan; 63(2):284-92. PubMed ID: 9020332 [TBL] [Abstract][Full Text] [Related]
3. Tolerance to heart and kidney grafts induced by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) versus depleting anti-CD4 monoclonal antibody (OX-38) with donor antigen administration. Motoyama K; Arima T; Lehmann M; Flye MW Surgery; 1997 Aug; 122(2):213-9; discussion 219-20. PubMed ID: 9288125 [TBL] [Abstract][Full Text] [Related]
4. Single dose anti-CD4 monoclonal antibody for induction of tolerance to cardiac allograft in high- and low-responder rat strain combinations. Qi Z; Riesbeck K; Ostraat O; Tufveson G; Ekberg H Transpl Immunol; 1997 Sep; 5(3):204-11. PubMed ID: 9402687 [TBL] [Abstract][Full Text] [Related]
5. Anti-CD4 therapy in combined heart-kidney, heart-liver, and heart-small bowel allotransplants in high-responder rats. Yin DP; Sankary HN; Talor-Edwards C; Chong AS; Foster P; Shen J; Ma LL; Williams JW; Fathman CG Transplantation; 1998 Jul; 66(1):1-5. PubMed ID: 9679814 [TBL] [Abstract][Full Text] [Related]
6. Administration of anti-CD4 monoclonal antibody with intrathymic injection of alloantigen results in rat cardiac allograft tolerance. Arima T; Goss JA; Walp LA; Flye MW Surgery; 1995 Aug; 118(2):265-72; discussion 272-3. PubMed ID: 7638743 [TBL] [Abstract][Full Text] [Related]
16. Anti-CD4 monoclonal antibody treatment combined with total lymphoid irradiation and cyclosporin A in hamster-to-rat cardiac transplantation. Analysis of lymphocyte subsets and anti-donor xenoantibodies. Steinbrüchel DA; Madsen HH; Lillevang S; Nielsen B; Kemp E Transpl Immunol; 1993; 1(3):209-16. PubMed ID: 7915954 [TBL] [Abstract][Full Text] [Related]
17. Role of double-negative regulatory T cells in long-term cardiac xenograft survival. Chen W; Ford MS; Young KJ; Cybulsky MI; Zhang L J Immunol; 2003 Feb; 170(4):1846-53. PubMed ID: 12574350 [TBL] [Abstract][Full Text] [Related]
18. Pretransplant administration of a single donor class I major histocompatibility complex molecule is sufficient for the indefinite survival of fully allogeneic cardiac allografts: evidence for linked epitope suppression. Wong W; Morris PJ; Wood KJ Transplantation; 1997 May; 63(10):1490-4. PubMed ID: 9175815 [TBL] [Abstract][Full Text] [Related]
19. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts. Binder J; Lehmann M; Graser E; Hancock WW; Watschinger B; Onodera K; Sayegh MH; Volk HD; Kupiec-Weglinski JW Transplantation; 1996 Mar; 61(5):804-11. PubMed ID: 8607187 [TBL] [Abstract][Full Text] [Related]
20. Helper T lymphocyte unresponsiveness to cardiac allografts following transient depletion of CD4-positive cells. Implications for cellular and humoral responses. Bishop DK; Li W; Chan SY; Ensley RD; Shelby J; Eichwald EJ Transplantation; 1994 Sep; 58(5):576-84. PubMed ID: 7522364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]